Prothrombin complex concentrate: An effective therapy in reversing the coagulopathy of traumatic brain injury

Journal of Trauma and Acute Care Surgery

Volumn 74, Issue 1, 2013, Pages 248-253

  Joseph, Bellal ^a   Hadjizacharia, Pantelis ^a   Aziz, Hassan ^a   Kulvatunyou, Narong ^a   Tang, Andrew ^a   Pandit, Viraj ^a   Wynne, Julie ^a   O'Keeffe, Terence ^a   Friese, Randall S ^a   Rhee, Peter ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

coagulopathy of trauma; craniotomy; Prothrombin concentrate complex; rFVIIa; traumatic brain injury

Indexed keywords

FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; WARFARIN;

ABDOMINAL INJURY; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; BLUNT TRAUMA; CONTROLLED STUDY; CRANIOTOMY; DRUG USE; ERYTHROCYTE TRANSFUSION; FACE INJURY; FEMALE; HEALTH CARE COST; HUMAN; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NEUROSURGERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SYSTOLIC BLOOD PRESSURE; THORAX INJURY; THROMBOCYTE COUNT; THROMBOEMBOLISM; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

ADULT; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BRAIN INJURIES; FACTOR VIIA; FEMALE; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 84872094662     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e3182788a40     Document Type: Article

References (28)

1. Dewall J. The ABCs of TBI. Evidence-based guidelines for adult traumatic brain injury care. JEMS. 2010;35:54-61; quiz 63.
2. Harhangi BS, Kompanje EJ, Leebeek FW, Maas AI. Coagulation disorders after traumatic brain injury. Acta Neurochir (Wien). 2008;150:165-175; discussion 175.
3. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62: 307-310.
4. Spinella PC, Holcomb JB. Resuscitation and transfusion principles for traumatic hemorrhagic shock. Blood Rev. 2009;23:231-240.
5. Joseph B, Amini A, Friese RS. Factor IX complex for the correction of traumatic coagulopathy. J Trauma. 2012;72:828-834.
6. Stein DM, Dutton RP, Kramer ME, Handley C, Scalea TM. Recombinant factor VIIa: decreasing time to neurosurgical intervention in patients with severe traumatic brain injury. J Trauma. 2008;64:620-628.
7. Stein D, Dutton R, Hess J, Scalea T. Low-dose recombinant factor VIIa for trauma patients with coagulopathy. Injury. 2008;39:1054-1061.
8. Stein DM, Dutton RP, Kramer ME, Scalea TM. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. J Trauma. 2009;66:63-75.
9. Dutton RP, McCunn M, Hyder M, D'Angelo M, O'Connor J, Hess JR, Scalea TM. Factor VIIa for correction of traumatic coagulopathy. J Trauma. 2004;57:709-719.
10. Fries D, Haas T, Klingler A, et al. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathyVa porcine model. Br J Anaesth. 2006;97:460-467.
11. Brohi K. Trauma induced coagulopathy. JR Army Med Corps. 2009;155: 320-322
12. Meng ZH, Wolberg AS, Monroe DM 3rd, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma. 2003;55:886-891.
13. Piek J, Chesnut RM, Marshall LF, et al. Extracranial complications of severe head injury. J Neurosurg. 1992;77:901-907.
14. Kearney TJ, Bentt L, Grode M, Lee S, Hiatt JR, Shabot MM. Coagulopathy and catecholamines in severe head injury. J Trauma. 1992;32:608-611; discussion 611-612.
15. Beck KH, Mortelmans Y, Kretschmer V, Ho?ltermann W, Lukasewitz P. Comparison of solvent/detergent-inactivated plasma and fresh frozen plasma under routine clinical conditions. Infusionsther Transfusionsmed. 2000;27:144-148.
16. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785.
17. Staudinger T, Frass M, Rintelen C, et al. Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients. Intensive Care Med. 1999;25:1105-1110.
18. Ansell J, Hirsh J, Hylek E, American College of Chest Physicians. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:160S-198S.
19. Hirsh J, Fuster V, Ansell J, Halperin JL. American heart association/ American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol. 2003;41:1633-1652.
20. Levy JH, Tanaka K, Dietrich W. Periopertive hemostatic management of patients treated with vitamin K antagonists. Anesthesiology. 2008;109: 918-926.
21. Aguilar M, Hart RG, Kase CS, et al. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc. 2007;82:82-92.
22. Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, et al. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost. 2008; 6:622-631.
23. Safaoui MN, Aazami R, Hotz H, Wilson MT, Margulies DR. A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage. Am J Surg. 2009;197:785-790.
24. Thomas GO, Dutton RP, Hemlock B, et al. Thromboembolic complications associated with factor VIIa administration. J Trauma. 2007;62: 564-569.
25. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma. 2005;59:8-15.
26. Dickneite G, Dorr B, Kaspereit F, Tanaka KA. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model. J Trauma. 2010;68:1151-1157.
27. Holland L, Warkentin TE, Refaai M. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose. Transfusion. 2009;49:1171-1177.
28. O'Connell KA, Wood JJ, Wise RP, et al. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA. 2006;295: 293-298.